IL10 and parasitic infectious disease: Spleen cells from JES6-1-treated mice conferred a substantial protection (∼40% reduction in parasitemia) if we consider the high parasite inoculum used in mouse challenge, and we can envisage that concomitant treatment with additional immunotherapies such as anti-IL-10 mAb could further improve parasite control.